Three-Year EFS for Each Factor for Each of the DPAV Sensitivity
| Prognostic Factors . | 3-yr EFS of Patients for DPAV Sensitivity . | Log-Rank Test P Value . | ||
|---|---|---|---|---|
| . | SS . | IS . | RR . | . |
| Clinical group | ||||
| Standard-risk ALL (n = 109) | 0.889 | 0.788 | 0.602 | .016 |
| High-risk ALL (n = 87) | 0.774 | 0.576 | 0.484 | .109 |
| Immunologic classification | ||||
| cALL (n = 143) | 0.834 | 0.713 | 0.62 | .087 |
| non-cALL (n = 53) | 0.857 | 0.791 | 0.39 | .052 |
| Age | ||||
| Infant (<1 yr old, n = 10) | 0 | 0 | 0 | .734 |
| 1-9 yr old (n = 127) | 0.873 | 0.777 | 0.656 | .059 |
| >9 yr old (n = 59) | 0.9 | 0.559 | 0.517 | .159 |
| Initial WBC count (/μL) | ||||
| <10,000 (n = 88) | 0.791 | 0.758 | 0.673 | .201 |
| 10,000-50,000 (n = 66) | 0.75 | 0.85 | 0.472 | .002 |
| >50,000 (n = 42) | 0.656 | 0.363 | 0.327 | .175 |
| Prognostic Factors . | 3-yr EFS of Patients for DPAV Sensitivity . | Log-Rank Test P Value . | ||
|---|---|---|---|---|
| . | SS . | IS . | RR . | . |
| Clinical group | ||||
| Standard-risk ALL (n = 109) | 0.889 | 0.788 | 0.602 | .016 |
| High-risk ALL (n = 87) | 0.774 | 0.576 | 0.484 | .109 |
| Immunologic classification | ||||
| cALL (n = 143) | 0.834 | 0.713 | 0.62 | .087 |
| non-cALL (n = 53) | 0.857 | 0.791 | 0.39 | .052 |
| Age | ||||
| Infant (<1 yr old, n = 10) | 0 | 0 | 0 | .734 |
| 1-9 yr old (n = 127) | 0.873 | 0.777 | 0.656 | .059 |
| >9 yr old (n = 59) | 0.9 | 0.559 | 0.517 | .159 |
| Initial WBC count (/μL) | ||||
| <10,000 (n = 88) | 0.791 | 0.758 | 0.673 | .201 |
| 10,000-50,000 (n = 66) | 0.75 | 0.85 | 0.472 | .002 |
| >50,000 (n = 42) | 0.656 | 0.363 | 0.327 | .175 |
Abbreviations: standard-risk ALL, 1 to 9 years old and less than 50,000/μL initial WBC without CNS involvement; high-risk ALL, all patients except standard-risk ALL.